ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CNSY vs ICU // GROSS PROFIT MARGIN

Cerenome Inc. (NASDAQ) VS. SeaStar Medical Holding Corporation (NASDAQ) • 15-METRIC TALLY: CNSY 2 — ICU 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CNSY VS. ICU) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CNSY ICU SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE — 95.70% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) -10.50% 180.00% -190.50 ICU /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 4/9 -2.00 ICU /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 43.2 35.4 +7.80 CNSY /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $13.2M $12.2M $1.1M CNSY /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CNSY REV ICU REV CNSY GROSS % ICU GROSS % CNSY FCF ICU FCF
FY 2025 $5.2M $1.2M — 95.7% -$20.8M -$13.6M
FY 2024 $5.8M $135.0K — 98.0% -$10.7M -$16.0M
FY 2023 $4.9M $0 — — -$12.9M -$10.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CNSY // BETA —
ICU // BETA —